Logo
x

Search

Subscribe Now

Neurodegenerative

Celgene Licenses Aprinoia's APN-1607 an Imaging Tracer- for Neurodegenerative Diseases

Celgene Licenses Aprinoia's APN-1607 an Imaging Tracer- for Neurodegenerative Diseases

  • January 3, 2019
Lilly Collaborates with AC Immune (AC) to Develop Candidates for Neurodegenerative Diseases

Lilly Collaborates with AC Immune (AC) to Develop Candidates for Neurodegenerative Diseases

  • December 13, 2018
MiNA Therapeutics Collaborates with Nippon Shinyaku on RNAa Therapeutics for Rare Neurodegenerative Diseases

    MiNA Therapeutics Collaborates with Nippon Shinyaku on RNAa Therapeutics for Rare Neurodegenerative Diseases

    • April 5, 2024
    AbbVie and Enigma Biomedical Group (EBG-USA) Enter into a Licensing Agreement to Develop and Commercialize 4R Tau PET Imaging Biomarkers

      AbbVie and Enigma Biomedical Group (EBG-USA) Enter into a Licensing Agreement to Develop and Commercialize 4R Tau PET Imaging Biom...

      • January 19, 2024
      Michael Irizarry shares insights from the P-III clinical study of LEQEMBI, for the treatment of Alzheimer’s disease

        Michael Irizarry shares insights from the P-III clinical study of LEQEMBI, for the treatment of Alzheimer’s disease

        • November 27, 2023
        Gregory Bell, CMO at Attralus Shares Insights from its License Agreement with Ossianix to Use Ossianix’s Brain Shuttle Technology

          Gregory Bell, CMO at Attralus Shares Insights from its License Agreement with Ossianix to Use Ossianix’s Brain Shuttle Technology

          • May 30, 2023
          Cumulus Neuroscience Receives the US FDA’s Clearance of User-Friendly EEG Device At-Home Use for Neuropsychiatric and Neurodegenerative Conditions

            Cumulus Neuroscience Receives the US FDA’s Clearance of User-Friendly EEG Device At-Home Use for Neuropsychiatric and Neurodegener...

            • May 5, 2023
            EIP Pharma Entered into a Definitive Merger Agreement with Diffusion Pharmaceuticals to Advance Neflamapimod for Neurodegenerative Diseases

              EIP Pharma Entered into a Definitive Merger Agreement with Diffusion Pharmaceuticals to Advance Neflamapimod for Neurodegenerative...

              • March 31, 2023
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.